Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Cymbalta® (duloxetine) – Expanded indication
April 20, 2020 - The FDA approved Eli Lilly’s Cymbalta (duloxetine), for the treatment of fibromyalgia in adults and pediatric patients 13 years of age and older.
